Biotech Barbie' Tackles Human Embryo Editing

Canadian entrepreneur Cathy Tie, self-styled 'Biotech Barbie,' has launched Origin Genomics, a startup focused on editing human embryos to prevent severe genetic diseases. This endeavor follows her ex-husband He Jiankui's controversial creation of the first gene-edited babies, an act that led to his imprisonment. Tie aims for a transparent, regulator-approved approach, contrasting with He's secret methods.

Tie's company utilizes advanced gene editing tools to correct mutations, asserting that early-stage intervention is safer than postnatal gene therapies. Despite ethical debates and the specter of eugenics, Tie believes gene editing for disease prevention is inevitable and advocates for open research. She aims to demonstrate the technology's safety and potential for clinical use, even as competitors secure significant venture capital funding.

The field faces scrutiny, with parallels drawn to the atomic bomb's Manhattan Project, a name Tie's initial company bore. While Tie emphasizes disease prevention, the potential for enhancement remains a concern, though she states current technology is not ready for such applications. She believes regulators, not bioethicists, should define the boundaries of gene editing use cases.

Tie's career began with early success in science and entrepreneurship, including a Thiel Fellowship at 18, leading to ventures like Ranomics and Locke Bio. Her personal life took a dramatic turn with her brief marriage to He Jiankui, which ended due to their inability to be in the same country, an event that caused her significant personal and professional challenges.